2019
Press Releases
-
Two-Step Expansion and VR Technique Enlarges Tiny Microbes, Illuminating New Ways to Prevent and Treat Disease
-
Immunotherapy delays type 1 diabetes diagnosis in people at high risk
-
Margaret McCormick, PhD, Named Executive Director of Benaroya Research Institute at Virginia Mason
-
Homer Lane to Retire from Benaroya Research Institute at Virginia Mason
-
Benaroya Research Institute Team Finds Link Between New Type of Cell and a Deadly Inflammatory Disorder
-
Benaroya Research Institute Welcomes Two New Board Members
2018
Press Releases
-
BRI to Partner with The Allen Institute for Immunology, A New Research Endeavor Focused on Human Immune Health and Disease
-
BRI Celebrates Peter Linsley, PhD, Trailblazer in Immune Regulation
-
Virginia Mason Was a Clinical Trial Site for New Peanut Allergy Medication
-
Benaroya Research Institute Awarded Funding for Autoimmune Disease Research in Down Syndrome Population
-
Lynn Rose, PhD, Promoted to Chief of Scientific Administration
-
Benaroya Research Institute Scientists Uncover New Strategy for Stopping Breast Cancer
-
Benaroya Research Institute Welcomes Two New Board Members
-
Benaroya Research Institute Receives $5 Million Grant to Explore Personalized Treatments for Peanut Allergy
-
Margaret McCormick, PhD, Named Chief Administrative Officer at Benaroya Research Institute
Two-Step Expansion and VR Technique Enlarges Tiny Microbes, Illuminating New Ways to Prevent and Treat Disease
Immunotherapy delays type 1 diabetes diagnosis in people at high risk
Margaret McCormick, PhD, Named Executive Director of Benaroya Research Institute at Virginia Mason
Homer Lane to Retire from Benaroya Research Institute at Virginia Mason
Benaroya Research Institute Team Finds Link Between New Type of Cell and a Deadly Inflammatory Disorder
Benaroya Research Institute Welcomes Two New Board Members
-
BRI to Partner with The Allen Institute for Immunology, A New Research Endeavor Focused on Human Immune Health and Disease
-
BRI Celebrates Peter Linsley, PhD, Trailblazer in Immune Regulation
-
Virginia Mason Was a Clinical Trial Site for New Peanut Allergy Medication
-
Benaroya Research Institute Awarded Funding for Autoimmune Disease Research in Down Syndrome Population
-
Lynn Rose, PhD, Promoted to Chief of Scientific Administration
-
Benaroya Research Institute Scientists Uncover New Strategy for Stopping Breast Cancer
-
Benaroya Research Institute Welcomes Two New Board Members
-
Benaroya Research Institute Receives $5 Million Grant to Explore Personalized Treatments for Peanut Allergy
-
Margaret McCormick, PhD, Named Chief Administrative Officer at Benaroya Research Institute
